An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis
- 16 May 2003
- Vol. 22 (1) , 137-144
- https://doi.org/10.1016/s0264-410x(03)00300-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- r-Sm14 - pRSETA efficacy in experimental animalsMemórias do Instituto Oswaldo Cruz, 2001
- Vaccine Strategies against Schistosomiasis: From Concepts to Clinical TrialsInternational Archives of Allergy and Immunology, 2001
- A mimotope peptide‐based vaccine against Schistosoma mansoni: synthesis and characterizationImmunology, 2000
- CD4+ T Cells of Schistosomiasis Naturally Resistant Individuals Living in an Endemic Area Produce Interferon‐γ and Tumour Necrosis Factor‐α in Response to The Recombinant 14kdaSchistosoma mansoni Fatty Acid‐Binding ProteinScandinavian Journal of Immunology, 2000
- The global burden of intestinal nematode infections — Fifty years onParasitology Today, 1997
- This wormy world — Then and nowParasitology Today, 1997
- Controlling schistosomiasis by vaccination: A realistic option?Parasitology Today, 1995
- Schistosomiasis vaccine development: approaches and prospectsMemórias do Instituto Oswaldo Cruz, 1995
- Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?Memórias do Instituto Oswaldo Cruz, 1995
- Three‐dimensional structure of fatty‐acid‐binding protein from bovine heartEuropean Journal of Biochemistry, 1991